NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Infosys Approves Stock Incentives Worth Rs 52 Crore for CEO Salil Parekh

Infosys has approved stock incentives worth approximately Rs 52 crore for its chief executive officer and managing director, Salil Parekh. The grants, which are part of Parekh's annual performance-linked compensation structure, were approved by the board based on recommendations from the Nomination and Remuneration Committee.

The IT major reported a 27.8 percent quarter-on-quarter rise in net profit at Rs 8,501 crore, with revenue for the March quarter coming in at Rs 46,402 crore, a 2 percent sequential rise. The stock incentives are structured across multiple performance-linked plans, including Rs 34.75 crore under the annual performance equity grant, Rs 2 crore linked to ESG targets, Rs 5 crore tied to total shareholder return (TSR), and Rs 10 crore under the 2019 performance plan. In total, the grants amount to approximately Rs 51.75 crore and will vest over a period of one to two years, subject to performance conditions and milestones set by the board.

Type of GrantAmount (Rs crore)
Annual Performance Equity Grant34.75
ESG Targets2
Total Shareholder Return (TSR)5
2019 Performance Plan10
Total51.75

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The restricted stock units (RSUs) will be granted effective May 2, with the number of units determined based on the market price prior to the grant date. The grant is broadly in line with the previous year, when Infosys awarded stock incentives worth approximately Rs 50 crore to Parekh under similar performance-linked plans.

Infosys has not yet taken a call on wage hikes for this fiscal, with both the timing and quantum still under review, according to chief financial officer Jayesh Sanghrajka. The delay comes as the IT services sector continues to operate in a low-growth environment, with discretionary spending still under pressure and deal ramp-ups taking longer. Infosys has guided for 1.5 percent to 3.5 percent revenue growth for FY27, signaling continued caution even as deal pipelines remain steady.

The company's cautious approach to costs, including compensation, is a result of the challenging business environment. However, Infosys continues to invest in priority areas such as AI and digital capabilities. The ESOP grants to Parekh are part of a structured annual compensation framework and include performance-linked components tied to financial, ESG, and shareholder return metrics. The company had followed a similar structure in the previous year as well, with stock incentives forming a significant portion of executive pay.

Investor Takeaway

Infosys has approved stock incentives worth ₹52 crore for CEO Salil Parekh, but wage hike for employees remains undecided.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.